🇺🇸 Commercial
Ginkgo Bioworks
Ginkgo
Synthetic-biology platform offering autonomous strain-engineering foundries and cloud-lab access for antibody, enzyme, and cell-line programmes.
Location
Boston, USA
Domain
biology
Maturity
operational
Investment
$786M raised